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Protein energy malnutrition (PEM) is a syndrome that often results in immunodeficiency coupled with pancytopenia. Hemopoi-
etic tissue requires a high nutrient supply and the proliferation, differentiation and maturation of cells occur in a constant and
balanced manner, sensitive to the demands of specific cell lineages and dependent on the stem cell population. In the present
study, we evaluated the effect of PEM on some aspects of hemopoiesis, analyzing the cell cycle of bone marrow cells and the
percentage of progenitor cells in the bone marrow. Two-month-old male Swiss mice (N = 7-9 per group)  were submitted to PEM
with a low-protein diet (4%) or were fed a control diet (20% protein) ad libitum. When the experimental group had lost about 20%
of their original body weight after 14 days, we collected blood and bone marrow cells to determine the percentage of progenitor
cells and the number of cells in each phase of the cell cycle. Animals of both groups were stimulated with 5-fluorouracil. Blood
analysis, bone marrow cell composition and cell cycle evaluation was performed after 10 days. Malnourished animals presented
anemia, reticulocytopenia and leukopenia. Their bone marrow was hypocellular and depleted of progenitor cells. Malnourished
animals also presented more cells than normal in phases G0 and G1 of the cell cycle. Thus, we conclude that PEM leads to the
depletion of progenitor hemopoietic populations and changes in cellular development. We suggest that these changes are some
of the primary causes of pancytopenia in cases of PEM.
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Introduction
The four most important deficiency diseases in devel-
oping countries are protein-energy malnutrition (PEM),
xerophthalmia, nutritional anemias, and iodine deficiency
disorders (1). Of these, PEM is the most important and also
the most difficult to control. The immediate cause is usually
insufficient intake or improper utilization of energy and
protein (2,3).
PEM is one of the main causes of immunodepression
(4), modifying both the adaptive and innate immune sys-
tem, as well as impairing hemopoiesis by altering T-de-
pendent areas of the lymphoid tissue (5), decreasing phago-
cytosis (6), hindering respiratory burst, reducing nitric ox-
ide availability (7), down-regulating proinflammatory cy-
tokine production (8).
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The literature describes an alternation between leuko-
penia and leukocytes, especially in humans. This is con-
sistent with the fact that malnutrition is usually associated
with infection or chronic disease (9,10). However, conflict-
ing literature reports may be explained by the different
kinds of nutritional deficiencies and other associated patho-
logical processes. Even though the leukocyte response is
variable, there is evidence that in situations where malnu-
trition is not associated with other diseases, leukopenia
will tend to dominate (8,10,11).
Hemopoietic tissue, like all tissues that have a high rate
of cell renewal and proliferation, requires a large supply of
nutrients. The anemia, leukopenia and bone marrow hypo-
plasia that occur in a state of PEM seem to be the product
of inefficient hemopoiesis, and inefficient myelopoiesis in
particular (5,12). It has been reported that the proliferative
capacity of bone marrow and the spleen is hindered in
malnourished mice and that there is a reduction in the
number of pluripotent cells and an increase in the time
taken for a single cell cycle to be completed (13). Malnutri-
tion reduces the number of granulo-monocytic colony form-
ing units (14) and leads to DNA damage (15) and to
cytogenetic alterations (16). The exact mechanisms un-
derlying these findings are not clear. Thus, the objective of
the present study was to evaluate the proliferative capacity
of hemopoietic progenitor cells in mice during PEM.
Material and Methods
Diets
The murine diets were prepared in our laboratories.
Mineral and vitamin mixtures were prepared according to
the recommendations of the American Institute of Nutrition
for adult mice (17). Both diets contained 100 g/kg sucrose,
80 g/kg corn oil, 10 g/kg fiber, 2.5 g/kg choline bitartrate,
1.5 g/kg L-methionine, 40 g/kg mineral mixture, and 10 g/
kg vitamin mixture. The control diet contained 200 g/kg
casein and 556 g/kg cornstarch while the malnourished
diet contained 40 g/kg casein and 716 g/kg cornstarch.
Casein (>85% protein) was the protein source. Both diets
were isocaloric and provided 1716.3 kJ/100 g. Final pro-
tein content was confirmed using the standard micro-
Kjeldahl method (18).
Animals
Male outbred Swiss mice 2 to 3 months of age were
obtained from the Faculty of Pharmaceutical Sciences,
University of São Paulo. The animals were placed in
individual “metabolic cages” and received the control diet
for 21 days. After this period of adaptation, the mice
reached a stable body weight. They were subsequently
divided into four groups, i.e., control (C), control + 5-
fluorouracil (C + 5F), malnourished (M), and malnourished
+ 5-fluorouracil (M + 5F). Each group was maintained
under a regular 12/12-h light/dark cycle at a temperature of
22-25°C and humidity of 55%. The groups received either
the control diet or the low-protein diet ad libtum and had
free access to water. Their body weight and food con-
sumption were monitored every 48 h. Mice were subjected
to experimental assays after 14 days of eating their re-
spective diets, by which time the malnourished group lost
about 20% of their original body weight (6). For the collec-
tion of the different biological samples, the animals were
first anesthetized with 10 mg/kg xylazine chlorohydrate
(Rompum®, Bayer, Brazil) and with 100 mg/kg ketamide
chlorohydrate (Ketamina®, Cristália, Brazil). The study was
approved by the Ethics Commission for Animal Studies of
the Faculty of Pharmaceutical Sciences, University of São
Paulo.
5-Fluorouracil administration
Animals from control and malnourished groups (C + 5F
and M + 5F) received 150 mg/kg 5-fluorouracil (American
Pharmaceutical Patterns, USA) intravenously via the cau-
dal vein, and after 10 days, control (C + 5F) and malnour-
ished (M + 5F) animals were anesthetized to permit collec-
tion of various biological samples.
Blood
The mice were anesthetized and whole blood samples
were obtained by cardiac puncture. The blood samples
were collected into tubes containing EDTA as anticoagu-
lant (Sigma, USA). Hemoglobin concentration and hema-
tocrit were determined by standard methods (19). Total
cell counts were obtained using a Neubauer chamber
(Herka, Germany). Differential leukocyte counts were per-
formed on blood smears stained with standard May-
Grunwald and Giemsa solutions (Sigma). Plasma was
separated by centrifugation and the albumin and total
protein concentrations were determined by standard meth-
ods used in medical analysis (20,21).
Bone marrow cellularity
Femurs were removed under aseptic conditions, and
bone marrow cells were flushed from them using Fisher
medium (Sigma) supplemented with 10% fetal calf serum
(Cultilab, Brazil) and 50 U/mL heparin (Liquemine®, Roche,
Brazil). The resulting preparations were then used for the
myelogram and for flow cytometry. Total cell counts were
first carried out, followed by differential counts using a
cytocentrifuge. The smears were stained with standard
May-Grunwald and Giemsa solutions (Sigma). Differential
525
Braz J Med Biol Res 42(6) 2009
Reduction of hemopoietic progenitor cells in malnutrition
www.bjournal.com.br
cell counts were performed on the basis of counts of 300
cells per slide/animal.
Bone marrow progenitor quantification: CD45+/CD34+
and CD117+/CD34+
Flow cytometry was used to determine the fraction of
bone marrow cells from control and malnourished animals
that could be positively labeled with antibodies (phycoery-
thrin (PE) and fluorescein isothiocyanate (FITC); Becton
Dickinson Pharmigen, USA) against CD45 (FITC, LY-5,
clone 30-F11), CD34 (PE, clone RAM 34), and CD117
(FITC, clone 2B8). The isotype controls were rat immuno-
globulins IgG 2a kappa, FITC (clone R35-95) for CD34 and
IgG 2b kappa FITC (clone A95-1) for CD45 and CD117.
For the immunophenotyping experiments, total cell sus-
pensions were first obtained from bone marrow. The
samples and negative controls were incubated with 1 μg
monoclonal antibody/106 cells/mL for 20 min in the dark at
25°C. After this period, the erythrocytes were lysed by
adding 2 mL 10% lysing solution (Lysing Solution®, Becton
Dickinson) and were incubated again for 15 min in the
dark. Next, the tubes were centrifuged at 400 g for 10 min,
the supernatant was discarded and the cell sediment was
washed twice with phosphate-buffered saline (PBS; Sig-
ma) containing 0.1% azide. The sediment was re-sus-
pended in 500 μL 1% paraformaldehyde (Sigma) and cells
were counted with a flow cytometer. Dual parameter flow
cytometry was carried out with a fluorescence-activated
cell sorter (FACS)Calibur instrument (Becton Dickinson)
equipped with an argon laser. Excitation occurred at 488
nm for both FITC and PE. Fluorescence measurements
were obtained with a minimum of 1 x 104 cells. Data were
analyzed using the Cell Quest® software package and the
results are reported as percentage of gated populations.
Cell cycle assessments: propidium iodide and acridine
orange
We evaluated the cell cycle phases of bone marrow
cells from both control and malnourished groups with or
without 5-fluorouracil using propidium iodide and acridine
orange staining.
Propidium iodide
Bone marrow cells collected from all groups were ad-
justed to a final concentration of 1 x 106 cells/mL in PBS.
Nine milliliters 100% ethanol (Sigma) was added to 1 mL of
a cell suspension that was subsequently maintained at
4°C for 4 h. The samples were then centrifuged for 5 min at
300 g, at 20-25°C. After centrifugation, the pellet was re-
suspended in 200 μL propidium iodide solution of the
following composition: 50 μL propidium iodide (Becton
Dickinson Pharmigen), 400 μL Triton X-100 (Sigma), 200
μL ribonuclease (Sigma), and 4350 μL PBS. The analyses
were performed by flow cytometry using the FACSCalibur
instrument (Becton Dickinson) equipped with an argon
laser. Excitation occurred at 488 nm. Data were analyzed
using the Cell Quest® software package.
Acridine orange
A 100-μL bone marrow cell suspension was prepared
from each group. Each suspension contained 2 x 106 cells/
mL. To this we added 400 μL acid solution detergent (0.1%
Triton X-100, 0.08 N HCl, 1.5 M NaCl). After 15 s 600 μL 20
μm acridine orange (Sigma), pH 6.0, was added. Cell
fluorescence was determined with the FACSCalibur in-
strument (Becton Dickinson) equipped with an argon laser.
Excitation occurred at 488 nm and detection was per-
formed with green 530 ± 20 nm and red 620 nm illumina-
tion. Under these conditions, the intensity of green fluores-
cence is proportional to the DNA content, while the inten-
sity of red fluorescence corresponds to the RNA content
(22). Data were analyzed using the Cell Quest® software.
Statistical analysis
The dependent variables were normally distributed.
Data are reported as means ± SEM (one-way analysis of
variance, ANOVA) and were compared by the Tukey mul-
tiple comparison test, with the level of significance set at P
≤ 0.05.
Results
Food and protein consumption, body weight variation,
albumin and total plasma protein concentrations
Mice treated or not with 5-fluorouracil and maintained
on the low-protein diet had reduced food and protein
consumption, resulting in weight loss, as well as a signifi-
cant reduction of protein consumption and, consequently,
decreased albumin and total plasma protein concentra-
tions (Table 1).
Blood and bone marrow cellularity
The undernourished animals treated or not with 5-
fluorouracil presented anemia with reticulopenia. They
also exhibited leukopenia with granulocytic and lympho-
cytic depletion compared to their respective control groups
(Table 2).
Differential counts of bone marrow cells from malnour-
ished animals treated or not with 5-fluorouracil (Table 2)
indicated a significant reduction in granulocytic cells, mac-
rophages and erythroblasts. Malnourished mice of both
groups exhibited a significant reduction in cell counts from
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Table 1. Daily food and protein consumption, body weight variation, albumin concentration, and total plasma protein of control and
malnourished animals treated or not with 5-fluorouracil.
Parameters Control Malnourished
Without 5-fluorouracil 10 days after Without 5-fluorouracil 10 days after
(N = 9) 5-fluorouracil (N = 7) (N = 9)  5-fluorouracil (N = 7)
Food consumption (g·day-1·animal-1) 5.9 ± 0.28 5.6 ± 0.31 4.4 ± 0.18a,b 4.1 ± 0.27a,b
Protein consumption (g·day-1·animal-1) 1.18 ± 0.18 1.12 ± 0.12 0.18 ± 0.04a,b 0.17 ± 0.09a,b
Body weight variation (%) 4.19 ± 0.8 4.1 ± 0.6 -22.2 ± 1.4a,b -23.7 ± 1.9a,b
Albumin concentration (g/dL) 4.2 ± 0.6 4.7 ± 0.6 3.1 ± 0.4a,b 3.0 ± 0.6a,b
Total plasma protein (g/dL) 7.20 ± 0.98 6.8 ± 1.1 4.80 ± 0.81a,b 4.30 ± 0.88a,b
Data are reported as means ± SEM. aP ≤ 0.05 control group without 5-fluorouracil compared to the other groups; bP ≤ 0.05 control
group with 5-fluorouracil compared to the other groups (one-way ANOVA).
Table 2. Number of erythrocytes, hemoglobin concentration, hematocrit, number of reticulocytes and total number of leukocytes,
neutrophils, lymphocytes, monocytes, and total and differential counts of bone marrow cells from the control and malnourished
animals treated or not with 5-fluorouracil.
Parameters Control Malnourished
Without 5-fluorouracil 10 days after Without 5-fluorouracil 10 days after
(N = 9) 5-fluorouracil (N = 7) (N = 9)  5-fluorouracil (N = 7)
Erythrocytes (x 106/mm3) 9.04 ± 0.88 9.53 ± 0.17 7.15 ± 0.93a,b 7.16 ± 0.80a,b
Hemoglobin (g/dL) 13.46 ± 2.44 12.83 ± 0.32 10.14 ± 1.03a,b 9.75 ± 0.65a,b
Reticulocytes (%) 4.53 ± 0.79 11.30 ± 3.88a 2.49 ± 0.65a,b 1.35 ± 1.08a,b
Peripheral leukocytes (/mm3) 2833 ± 211 3050 ± 183 1193 ± 111a,b 1026 ± 54.1a,b
Peripheral neutrophils (/mm3) 1395 ± 181 1992 ± 97.9a 339 ± 15.6a,b 402 ± 2.25a,b
Peripheral lymphocytes (/mm3) 1468 ± 183 1058 ± 59.9 703 ± 24.5a,b 624 ± 3.26a,b
Peripheral monocytes (/mm3) 3.14 ± 2.33 0.06 ± 0.01a 7.80 ± 1.26a,b 0.06 ± 0.01a,c
Total bone marrow cells (x 105/mm3) 151.7 ± 33.1 94.3 ± 37.1a 84.4 ± 25.3a 36.9 ± 6.6a,b,c
Bone marrow blast cells (x 105/mm3) 1.69 ± 0.65 0.72 ± 0.43a 0.76 ± 0.32a 0.41 ± 0.31a
Bone marrow promyelocytic, myelocytic 11.16 ± 2.49 3.51 ± 0.98a 3.63 ± 2.78a 1.81 ± 0.42a,b,c
and metamyelocytic cells (x 105/mm3)
Bone marrow band cells (x 105/mm3) 19.81 ± 2.42 8.21 ± 1.31a 6.92 ± 1.21a 4.67 ± 1.56a,b
Bone marrow segmented (x 105/mm3) 50.01 ± 4.36 30.01 ± 2.36a 17.69 ± 2.18a,b 11.99 ± 2.76a,b,c
Bone marrow eosinophils (x 105/mm3) 3.37 ± 2.96 1.01 ± 0.89 1.01 ± 1.90 0.54 ± 0.24a
Bone marrow lymphocytes (x 105/mm3) 38.21 ± 2.04 18.06 ± 2.60a 26.48 ± 2.24a 17.84 ± 2.15a,c
Bone marrow macrophages (x 105/mm3) 2.52 ± 1.96  0.58 ± 0.60a 0.70 ± 0.70a 0.31 ± 0.48a
Bone marrow total erytroblasts (x 105/mm3) 43.64 ± 3.36 32.24 ± 2.43a 26.59 ± 2.81a,b 29.41 ± 2.68a,b
Data are reported as means ± SEM. aP ≤ 0.05 control group without 5-fluorouracil compared to the other groups; bP ≤ 0.05 control
group with 5-fluorouracil compared to the other groups. cP ≤ 0.05 malnourished group without 5-fluorouracil compared to the
malnourished group treated with 5-fluorouracil (one-way ANOVA).
all the maturation stages of the granulocytic lineage, con-
sistent with a significant reduction in the erythrocytic com-
ponent of the blood. Taken together, these results suggest
a state of marrow failure, possibly due to the reduction of
progenitor bone marrow cells.
Flow cytometry results: progenitor populations
The immunophenotypic analysis demonstrated the
presence of three distinct cell populations; gate R1 was
chosen to analyze progenitor antigen expression. Bone
marrow cells from malnourished mice not treated with 5-
fluorouracil had a reduced number of cells expressing low
intensity fluorescence (CD45) when compared with the
control group that did not receive 5-fluorouracil. This indi-
cates a reduction in the number of progenitor cells, as
confirmed by the smaller number of cells, which expressed
CD45+/CD34+ and CD117+/CD34+ (Figure 1). In malnour-
ished animals that received 5-fluorouracil, the results were
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similar, with fewer cells expressing CD45
compared with control animals that re-
ceived 5-fluorouracil (data not shown).
Cell cycle
The cell cycle in bone marrow cells
was evaluated using the propidium iodide
technique and flow cytometry (Table 3).
Control animals showed a lower percent-
age of cells in the G0/G1 phases than did
malnourished animals. The control ani-
mals presented a higher percentage of
cells in the S/G2/M phases compared to
malnourished animals. Control animals
that received 5-fluorouracil also presented
fewer cells in the G0/G1 phase compared to their respec-
tive malnourished groups.
Analysis of the cell cycle using the acridine orange
technique (Table 4) showed that animals from the control
group had fewer cells in the G0 phase compared to mal-
nourished animals. Control animals, which received 5-
Table 3. G0/G1 cell cycle phases and S/G2/M cell cycle phases of bone marrow
cells from the control and malnourished animals treated or not with 5-fluorouracil
using the propidium iodide technique.
Parameters Control Malnourished
Without 10 days after Without 10 days after
5-fluorouracil 5-fluorouracil 5-fluorouracil  5-fluorouracil
(N = 9)  (N = 7) (N = 9)  (N = 7)
G0/G1 80.17 ± 2.68 78.84 ± 2.32 87.12 ± 2.73a,b 84.99 ± 0.44a,b
S/G2/M 19.78 ± 2.64 19.77 ± 8.36 13.32 ± 2.32a 19.61 ± 4.54
Data are reported as means ± SEM. aP ≤ 0.05 control group without 5-fluorouracil
compared to the other groups; bP ≤ 0.05 control group with 5-fluorouracil compared
to the other groups (one-way ANOVA).
Figure 1. A, Flow cytometry analyses of bone
marrow from control and malnourished mice
shows the selections of gates R1, R2 and R3
of the cell populations that were not marked
with fluorochromes (SSC on the y-axis vs FSC
on the x-axis). The immunophenotypic bone
marrow analysis was carried out in gate R1
and shows CD45 vs CD34 cells and CD117
vs CD34 cells from the bone marrow of control
(N = 6) and malnourished (N = 6) animals. The
graphs are representative of the five inde-
pendent experiments, each showing similar
results. A total of 104 cells were analyzed in a
flow cytometer using a 488-nm argon laser,
FACSCalibur (Becton Dickinson). SSC = side
scatter; FSC = forward scatter; PE = phycoer-
ythrin; FITC = fluorescein isothiocyanate. *P ≤
0.05 compared to control (one-way ANOVA).
fluorouracil, also presented fewer G0 cells than the re-
spective malnourished group.
Both the propidium iodide technique and the acridine
orange test showed that malnourished animals had a
higher percentage of cells in the G0 phase of the cell cycle.
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104103102101100
CD117 FITC
104103102101100
CD117 FITC
Malnourished
1.9 ± 0.13% 0.9 ± 0.11%*
74.7 ± 3.1% 20.1 ± 4.1%*
1000
800
600
400
200
0
S
S
C
-H
ei
gh
t
1000
800
600
400
200
0
S
S
C
-H
ei
gh
t
200 400 600 800 10000 200 400 600 800 10000
FSC-Height
MO 16.01.03.024 MO 16.01.03.007
104
103
102
101
100
C
D
34
 P
E
104
103
102
101
100
C
D
34
 P
E
104103102101100
CD45 FITC
104103102101100
CD45 FITC
104
103
102
101
100
C
D
34
 P
E
104
103
102
101
100
C
D
34
 P
E
FSC-Height
528
Braz J Med Biol Res 42(6) 2009
P. Borelli et al.
www.bjournal.com.br
Discussion
This study confirms that protein malnutrition produces
alterations in bone marrow that lead to cellular depletion.
This, in turn, results in anemia with significant reticulocyte
reduction and leukopenia. The immunophenotypic analy-
sis demonstrated the depletion of progenitor populations
and the cell cycle analysis showed that more cells were in
the G0 phase in the malnourished animals.
Since the minimum daily amounts of nutrients other
than protein were ingested by the animals of the malnour-
ished group, we may conclude that the changes observed
in our experimental model are mainly the result of the
decrease in protein and energy intake.
According to Suda et al. (23), the weaker leukocyte
response to bacterial infections in protein-energy malnutri-
tion is due to a reduction in the reserve compartment of the
bone marrow. Deo (24) observed that monkeys submitted
to low-protein diets presented alterations in the intestinal
mucosa secondary to a decrease in cell proliferation. Fried
et al. (9) reported that mice submitted to protein-free diets,
after receiving sublethal doses of radiation, presented a
reduction in the number of granulocytic colony forming
units. Ortiz and Betancourt (25) demonstrated a relation-
ship between protein deficiency and the proliferation of
hemopoietic cells. The bone marrow hypocellularity found
in this study was also reported by Fló et al. (26) and Olmos
et al. (16).
Our study showed that malnourished animals present
a higher percentage of cells in the G0 phase of develop-
ment. This is combined with a smaller number of cells
exhibiting CD34+, CD45+ and CD117+. We conclude that
this is one of the factors responsible for the marrow hypo-
plasia observed here, partially explaining
our results (27,28).
The reason for administering 5-fluoro-
uracil was to halt the development of most
bone marrow cells at or even before the
G0 phase of the cell cycle. Our goal was to
subsequently evaluate the ability of the
cells to resume development. Ten or 15
days after 5-fluorouracil administration,
our results demonstrated that cells from
the malnourished animals were not as
readily able to resume development as
those from the control animals (data not
shown).
The anemia, leukopenia and marrow
atrophy found in the mice submitted to
protein-energy malnutrition suggest a de-
crease in the proliferative capacity of pro-
genitor cells. The decrease in the marrow compartment
was a result of more cells in the G0 phase of the cell cycle
and was not a result of an increase of the efflux of bone
marrow cells to peripheral blood and/or an increase in
apoptosis. Our group (27) used clonogenic assays to
demonstrate that cells from the bone marrow of malnour-
ished animals showed less ability to differentiate.
One of the prerequisites for hemopoiesis is the estab-
lishment of stem cells within the microenvironment in order
to enable possible cell-cell and cell-extracellular matrix
(ECM) interactions (29). Hemopoiesis occurs within the
context of the unique marrow microenvironment, where
stromal cells and components of the ECM modulate the
growth and differentiation of hemopoietic progenitors (30).
Few studies exist that explore the relationship between
malnutrition and the ECM. Lyra et al. (31) observed an
increase in ECM density within the thymus in malnour-
ished children, which was considered to be responsible for
the depletion of thymocytes. Reif et al. (32) found a de-
crease in ECM components within the liver.
The mechanisms that lead to these changes have not
been elucidated. Considering that ECM molecules are
involved in the adhesion, regulation, proliferation, differen-
tiation, and migration of hematopoietic cells, these changes
may be highly significant for the physiology of the tissue.
In ex vivo cultures, the population of progenitor cells in
the S/G2/M phases is mostly related to fibronectin. In
contrast, cells in G0 are more frequently not adhered. This
suggests that cell cycle transition is associated with adhe-
sion to fibronectin (33,34). However, the activation of the
cell cycle does not cause adhesion of the cell to fibronectin
since cells in various stages of the cell cycle have been
found in non-adherent fractions. Giet et al. (33) also ob-
Table 4. Total G0, G1, S, and G2/M cell cycle phases of bone marrow cells from
control and malnourished animals treated or not with 5-fluorouracil using the acri-
dine orange technique.
Parameters Control Malnourished
Without 10 days after Without 10 days after
5-fluorouracil 5-fluorouracil 5-fluorouracil  5-fluorouracil
(N = 9)  (N = 7) (N = 9)  (N = 7)
G0 28.13 ± 4.18 54.91 ± 11.75a 54.17 ± 15.76a 60.17 ± 3.85a,b,c
G1 53.96 ± 3.83 38.95 ± 12.28a 31.32 ± 14.90a 20.76 ± 7.10a,b,c
S 9.51 ± 3.09 8.79 ± 2.50 6.20 ± 2.91a 8.24 ± 2.79c
G2/M 8.72 ± 4.50 10.97 ± 6.63 5.91 ± 0.94a 10.87 ± 2.11c
Data are reported as means ± SEM. aP ≤ 0.05 control group without 5-fluorouracil
compared to the other groups; bP ≤ 0.05 control group with 5-fluorouracil compared
to the other groups. cP ≤ 0.05 malnourished group without 5-fluorouracil compared
to the malnourished group treated with 5-fluorouracil (one-way ANOVA).
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served that cell adhesion consistent with the phase of
development is mediated by VLA-5. Cytokine-related stim-
ulation allows the overexpression of this receptor. The
abnormalities found in ECM components could alter the
co-localization of the diverse growth factors and cytokines,
which are required to modulate the growth and differentia-
tion process of hematopoietic cells (12,28,35). This in turn
may alter the cell-cell and cell-ECM interactions, thereby
modifying the signaling pathways and leading to bone
marrow hypoplasia with a depletion of progenitor hemato-
poietic populations and peripheral pancytopenia. These
data may partially justify the increase in susceptibility to
infection observed in malnourished individuals.
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